OFFICIAL PUBLICATION OF

by its subsidiary APPco

Statins vindicated: review

Megan Haggan 09/09/2016

The potential harms of statins have been exaggerated and their benefits underestimated, a new review has found.Statins have taken a beating in the media recently: in Australia, a Catalyst two-part piece which was subsequently retracted, and in the UK, reports following a 2013 BMJ article questioned the efficacy and side effect profile of the drug

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

What does the future look like for CWH/Sigma shareholders?

Yeh but CWH's entire business model is to go to areas with low rent and charge below cost prescriptions and…

Bob Tran

What does the future look like for CWH/Sigma shareholders?

if they can't grow internally they can easily acquire other store and distribution centre and shareholder would be more than…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Ponraj unlike Coles CWH sell medications LOL - if they can't grow internally they can easily acquire other store and…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Undervalued. With the data Sigma have on your purchasing (even if not primary supplier), combined with what they receive from…

Justin Levine

Statins vindicated: review

Previous UK cuts likely delayed, not cancelled

Next Qualified support: Small Business Minister

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous UK cuts likely delayed, not cancelled

Next Qualified support: Small Business Minister

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.